S&P 500 · Health Care · USD · FY end 2025-12-31
Boston Scientific (BSX) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 20.07B | 2.89B | 1.94 | 3.66B |
| FY2024 | 16.75B | 1.85B | 1.25 | 2.65B |
| FY2023 | 14.24B | 1.59B | 1.07 | 1.79B |
| FY2022 | 12.68B | 698.00M | 0.45 | 938.00M |
| FY2021 | 11.89B | 1.04B | 0.69 | 1.32B |